| abstract |
The present disclosure provides a compound, or a pharmaceutically acceptable salt thereof, for use in inhibiting the growth of a microorganism; treating a microbial infection, malaria, mucositis, ocular infection, ear infection, cancer, or mycobacteria ( Mycobacterium) Infected mammal; kills or inhibits the growth of Plasmodium species; inhibits the growth of Mycobacterium species; regulates immune responses in mammals; or antagonizes unfractionated heparin, low molecular weight heparin, Or heparin/low molecular weight heparin derivatives. |